$158,000 ALS drug pulled from market after failing in large clinical trial
Ars Technica - 2024-04-05T22:28:52.000Z

The drug is now unavailable to new patients; its maker to lay off 70% of employees. Read this story

Related Articles

[Photos] Karbala: Large crowds of pilgrims perform Eid Al-Fitr prayers in Bayn al-Haramayn
by Shafaqna English
Trump’s trial starts: After failed delay tactics, Trump becomes 1st ex-POTUS to face criminal trial
by MSNBC
Jailed drug lord El Chapo is lonely in his Supermax jail cell and has begged judge to let him chat with wife and daughters: Once bragged of killing 2,000-3,000 people
by Daily Mail

House speaker delays doomed-to-fail impeachment trial
by Daily Kos
Why Denmark's hippy Christiania is closing down its open drug market
by @thelocaldenmark
More Related Articles

Latest in News

Higher Ground: Community Science Unifies Us Around Climate Change
by WNYC
Magnificent Seven ETF (MAGS) Hits New 52-Week High
by Zacks Investment Research
Ravindra Jadeja turns Superman to pull off a one-handed blinder, leaves skipper Ruturaj Gaikwad in total disbelief. Watch
by Times of India

Nate Diaz targeted in new Rodney Petersen lawsuit for New Orleans street brawl, Diaz rep responds
by MMA Fighting
In photos: Moments from Washington for the week of April 16, 2024 - All Photos
by UPI.com
Colorado Rockies' Recent United Airlines Charter Flight Under Federal Investigation
by Sports Illustrated

More from Ars Technica | Health Science ALS Amylyx clinical trial fda